BREAKING
Home » Posts Tagged "hepatitis C treatment"

Hepatitis C treatment: Mavyret approved as first eight-week treatment

By

The U.S. Food and Drug Administration today expanded the approval of Mavyret (glecaprevir and pibrentasvir) tablets for an eight-week duration for the treatment of adults and children ages 12 years and...

Hepatitis C direct-acting antivirals: 85 percent of Canadian provinces and territories restrict access

By

A pill a day for 12 weeks. The new direct-acting antivirals (DAA) are effective in curing the hepatitis C virus infection, a potentially fatal disease that attacks the liver. But they are expensive–approximately...

Rhode Island reports ‘significant increase’ in hepatitis C deaths

By

Rhode Island has seen a significant increase in hepatitis C virus-related hospitalizations and deaths in the last decade, underscoring the importance of diagnosis and treatment, according to a new report...

Hepatitis C drug, Epclusa, receives FDA nod to treat chronic infection

By

First regimen to treat all six major HCV genotypes The U.S. Food and Drug Administration approved Epclusa to treat adult patients with chronic hepatitis C virus (HCV) both with and without cirrhosis (advanced...

Bristol-Myers Squibb’s hepatitis C drug, Daklinza, receives FDA approval

By

The U.S. Food and Drug Administration today approved Daklinza (daclatasvir) for use with sofosbuvir to treat hepatitis C virus (HCV) genotype 3 infections. Daklinza is the first drug that has demonstrated...

Viekira Pak gets FDA approval for treating chronic hepatitis C virus

By

The U.S. Food and Drug Administration today approved Viekira Pak (ombitasvir, paritaprevir and ritonavir tablets co-packaged with dasabuvir tablets) to treat patients with chronic hepatitis C virus (HCV)...